| Followers | 43 |
| Posts | 4765 |
| Boards Moderated | 3 |
| Alias Born | 04/14/2008 |
Wednesday, May 26, 2010 2:12:59 PM
i guess i don't know how to communicate this any differently:
"of course you do realize i was talking about their next installment, right?
the VWAP is declining and by june, they're going to receive over 400k shares - "
potentially a LOT more than 400k shares - between the market cap, the consistent volume to the downside - no reasonable expectation of earth shattering news, disqualification to uplisting per AMEX standards -
i mean, there are years and years of studies left to be done -
the investors shouldn't worry about the price action today or tomorrow or next week, unless they expected the doctors to deliver when they indicated that the $5MM would be enough to uplist without considering the ramifications of the deal they struck relative to the stock price - if that's what investors were banking on, they should rightfully be disappointed -
"of course you do realize i was talking about their next installment, right?
the VWAP is declining and by june, they're going to receive over 400k shares - "
potentially a LOT more than 400k shares - between the market cap, the consistent volume to the downside - no reasonable expectation of earth shattering news, disqualification to uplisting per AMEX standards -
i mean, there are years and years of studies left to be done -
the investors shouldn't worry about the price action today or tomorrow or next week, unless they expected the doctors to deliver when they indicated that the $5MM would be enough to uplist without considering the ramifications of the deal they struck relative to the stock price - if that's what investors were banking on, they should rightfully be disappointed -
Bernie Madoff [with my money]
a haiku by uncle soy
gray-haired bandido,
the target of grumpiness,
where's the benjamins?
Recent NNVC News
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:07:54 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2025 08:33:17 PM
